Empirical therapy for cardiac implantable electronic device lead endocarditis
Empirical therapy for cardiac implantable electronic device lead endocarditis is directed against Staphylococcus aureus and coagulase-negative staphylococci because these are the most common causative organismsHan, 2021. Additional therapy against a broader range of pathogens is required if the patient has signs of septic shock.
For empirical treatment of cardiac implantable electronic device lead endocarditis in adults and children without signs of septic shock, use:
vancomycin intravenously; for initial dosing, see Intermittent vancomycin dosing for noncritically ill adults or Intermittent vancomycin dosing for young infants and children. vancomycin vancomycin vancomycin
For empirical treatment of cardiac implantable electronic device lead endocarditis in adults and children with signs of septic shock, treat as for Empirical therapy for prosthetic valve endocarditis.